Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-12

FDA Approved: OFLOXACIN — Original Application (Leading Pharma, LLC)

View source ↗

Summary

FDA approved the original application for OFLOXACIN ophthalmic solution 0.3% from Leading Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OFLOXACIN (OFLOXACIN)

Snippet

ORIG AP for OFLOXACIN (OFLOXACIN)